Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Support Provided By
26:45
December 13, 2025 - PBS News Weekend full episode
57:46
December 12, 2025 - PBS News Hour full episode
57:46
December 11, 2025 - PBS News Hour full episode
57:46
December 10, 2025 - PBS News Hour full episode
56:45
December 9, 2025 - PBS News Hour full episode
56:45
December 8, 2025 - PBS News Hour full episode
24:09
December 7, 2025 - PBS News Weekend full episode
24:09
December 6, 2025 - PBS News Weekend full episode
57:46
December 5, 2025 - PBS News Hour full episode
57:46
December 4, 2025 - PBS News Hour full episode
57:46
December 3, 2025 - PBS News Hour full episode
57:46
December 2, 2025 - PBS News Hour full episode